Purdue Pharma, the drug giant many have blamed for the ongoing U.S. opioid abuse crisis, has offered $10 billion to $12 billion to settle more than 2,000 lawsuits lodged against it, NBC News is reporting.
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements its prospects in the field.